Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal modelsHan-Yi Huang, Chi‐Huey Wong, Yi-Hsuan Chang et al.|Science Translational Medicine|2022Cited by 127
Differential Receptor Binding Affinities of Influenza Hemagglutinins on Glycan ArraysHsin-Yu Liao, Chi‐Huey Wong, Che‐Hsiung Hsu et al.|Journal of the American Chemical Society|2010Cited by 93
Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2Yu-Pu Juang, Pi‐Hui Liang, Yu-Ting Chou et al.|European Journal of Medicinal Chemistry|2022Cited by 19
Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutininMingwei Chen, Chi‐Huey Wong, Hsin-Yu Liao et al.|Proceedings of the National Academy of Sciences|2011Cited by 18
Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furinCheng‐Wei Yang, Shiow‐Ju Lee, Hsing‐Yu Hsu et al.|Biochemical Pharmacology|2023Cited by 17